Literature DB >> 18708346

Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2.

Donggoo Bae1, Shaolei Lu, Cherie A Taglienti, Arthur M Mercurio.   

Abstract

The neuropilins-1 and -2 (NRP1 and NRP2) function as receptors for both the semaphorins and vascular endothelial growth factor. In addition to their contribution to the development of the nervous system, NRP1 and NRP2 have been implicated in angiogenesis and tumor progression. Given their importance to cancer and endothelial biology and their potential as therapeutic targets, an important issue that has not been addressed is the impact of metabolic stress conditions characteristic of the tumor microenvironment on their expression and function. Here, we demonstrate that hypoxia and nutrient deprivation stimulate the rapid loss of NRP1 expression in both endothelial and carcinoma cells. NRP2 expression, in contrast, is maintained under these conditions. The lysosomal inhibitors chloroquine and bafilomycin A1 prevented the loss of NRP1 expression, but proteasomal inhibitors had no effect. The hypothesis that NRP1 is degraded by autophagy is supported by the findings that its expression is lost rapidly in response to metabolic stress, prevented with 3-methyladenine and induced by rapamycin. Targeted depletion of NRP2 using small hairpin RNA revealed that NRP2 can function in the absence of NRP1 to mediate endothelial tube formation in hypoxia. Studies aimed at assessing NRP function and targeted therapy in cancer and angiogenesis should consider the impact of metabolic stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18708346      PMCID: PMC2568914          DOI: 10.1074/jbc.M804203200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  42 in total

1.  Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression.

Authors:  H Q Miao; P Lee; H Lin; S Soker; M Klagsbrun
Journal:  FASEB J       Date:  2000-12       Impact factor: 5.191

2.  Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections.

Authors:  H Chen; A Bagri; J A Zupicich; Y Zou; E Stoeckli; S J Pleasure; D H Lowenstein; W C Skarnes; A Chédotal; M Tessier-Lavigne
Journal:  Neuron       Date:  2000-01       Impact factor: 17.173

3.  Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy.

Authors:  H Ishihama; M Ohbayashi; N Kurosawa; T Kitsukawa; O Matsuura; Y Miyake; T Muramatsu
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-05       Impact factor: 4.799

4.  Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells.

Authors:  R E Bachelder; A Crago; J Chung; M A Wendt; L M Shaw; G Robinson; A M Mercurio
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

5.  Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions.

Authors:  S P Mathupala; A Rempel; P L Pedersen
Journal:  J Biol Chem       Date:  2001-09-13       Impact factor: 5.157

Review 6.  The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

Authors:  J M Brown
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

Review 7.  The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF.

Authors:  Gera Neufeld; Ofra Kessler; Yael Herzog
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

8.  Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

Authors:  Selma Pennacchietti; Paolo Michieli; Maria Galluzzo; Massimiliano Mazzone; Silvia Giordano; Paolo M Comoglio
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

9.  Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.

Authors:  Robin E Bachelder; Melissa A Wendt; Arthur M Mercurio
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

10.  Neuropilin-1 is differentially expressed in myoepithelial cells and vascular smooth muscle cells in preneoplastic and neoplastic human breast: a possible marker for the progression of breast cancer.

Authors:  John M Stephenson; Snigdha Banerjee; Neela K Saxena; Rachel Cherian; Sushanta K Banerjee
Journal:  Int J Cancer       Date:  2002-10-10       Impact factor: 7.396

View more
  25 in total

1.  Neuropilin-2 regulates α6β1 integrin in the formation of focal adhesions and signaling.

Authors:  Hira Lal Goel; Bryan Pursell; Clive Standley; Kevin Fogarty; Arthur M Mercurio
Journal:  J Cell Sci       Date:  2012-02-02       Impact factor: 5.285

Review 2.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

3.  Vascular endothelial growth factor-C protects prostate cancer cells from oxidative stress by the activation of mammalian target of rapamycin complex-2 and AKT-1.

Authors:  Michael H Muders; Heyu Zhang; Enfeng Wang; Donald J Tindall; Kaustubh Datta
Journal:  Cancer Res       Date:  2009-07-28       Impact factor: 12.701

4.  High mobility group box 1 promotes endothelial cell angiogenic behavior in vitro and improves muscle perfusion in vivo in response to ischemic injury.

Authors:  Ulka Sachdev; Xiangdong Cui; Guiying Hong; Seung Namkoong; Jenny M Karlsson; Catherine J Baty; Edith Tzeng
Journal:  J Vasc Surg       Date:  2011-09-23       Impact factor: 4.268

5.  Hypoxia induces tumor and endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner via transcriptional repression of their common receptor neuropilin 2.

Authors:  Silvia Coma; Akio Shimizu; Michael Klagsbrun
Journal:  Cell Adh Migr       Date:  2011-05-01       Impact factor: 3.405

6.  ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading.

Authors:  Paul Mak; Irwin Leav; Bryan Pursell; Donggoo Bae; Xiaofang Yang; Cherie A Taglienti; Lindsey M Gouvin; Vishva M Sharma; Arthur M Mercurio
Journal:  Cancer Cell       Date:  2010-04-13       Impact factor: 31.743

7.  Protein kinase LKB1 promotes RAB7-mediated neuropilin-1 degradation to inhibit angiogenesis.

Authors:  Imoh S Okon; Kathleen A Coughlan; Cheng Zhang; Cate Moriasi; Ye Ding; Ping Song; Wencheng Zhang; Guangpu Li; Ming-Hui Zou
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

Review 8.  Autophagy in tumor suppression and cancer therapy.

Authors:  Che-Pei Kung; Anna Budina; Gregor Balaburski; Marika K Bergenstock; Maureen Murphy
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2011       Impact factor: 1.807

Review 9.  Enhancing integrin function by VEGF/neuropilin signaling: implications for tumor biology.

Authors:  Hira Lal Goel; Arthur M Mercurio
Journal:  Cell Adh Migr       Date:  2012-10-17       Impact factor: 3.405

10.  Enhanced autophagy blocks angiogenesis via degradation of gastrin-releasing peptide in neuroblastoma cells.

Authors:  Kwang Woon Kim; Pritha Paul; Jingbo Qiao; Sora Lee; Dai H Chung
Journal:  Autophagy       Date:  2013-08-29       Impact factor: 16.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.